Investing Profile

Amir Nashat

VCInvestor

Managing Partner at Polaris Partners

polarispartners.com/partner/a...Cambridge, Massachusetts
Photo of Amir Nashat, Managing Partner at Polaris Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Polaris Partners Managing Partner
$300K - $2.0M
$500K
46
$4B
CompanyStageDateRound SizeTotal Raised
Dewpoint Therapeutics
Series CFeb 2022$150M
Series BSep 2020$77M
$230M
Co-investors: Kristina Burow (ARCH Venture Partners)
Freenome
Series DDec 2021$300M
Series CAug 2020$270M
Series BJul 2019$160M
Series AAug 2017$7M
Series AMar 2017$65M
$800M
Co-investors: Bill Maris (Section 32), Peter Kolchinsky (RA Capital), Jeffrey Schwartz (Bain Capital Life Sciences), Vasudev Bailey (Artis Ventures (AV)), Chris Leiter (Atria Ventures), Skip Fleshman (Asset Management Ventures)
Kojin Therapeutics
Series AJun 2021$60M
$60M
Primmune Therapeutics
Series AOct 2020$27M
$27M
Jnana
Series ADec 2017$50M
$50M
Co-investors: Kevin Kinsella (Avalon Ventures)
Jnana Therapeutics
Series ADec 2017$50M
$50M
Co-investors: Carlo Rizzuto (Versant Ventures)
Scholar Rock
Series BJan 2016$36M
Series ASep 2014$20M
$100M
Co-investors: Timothy A. Springer
Selecta Biosciences
Series ESep 2015$38M
Private Equity RoundOct 2014$20M
Series CApr 2010$15M
Series BFeb 2009$15M
$88M
Co-investors: Carl Gordon (OrbiMed), Aymeric Sallin (NanoDimension), Doug Cole (Flagship Ventures), Timothy A. Springer